EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advancing Clinical Pharmacogenomics Worldwide Through the Clinical Pharmacogenetics Implementation Consortium ( CPIC )

Kelly E Caudle iD, Michelle Whirl-Carrillo iD, Mary V Relling iD, James M Hoffman iD, Roseann S Donnelly iD, Cyrine E Haidar iD, Melissa S Bourque iD, Samantha Frear iD, Li Gong iD, Katrin Sangkuhl iD, Ryan Whaley iD, Teri E Klein iD

Clinical Pharmacology & Therapeutics · 2025-12 · 118 (6) · 1512-1522

DOI: 10.1002/cpt.70005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 18.07.2025. Verfasst von Kelly E Caudle und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Pharmacogenetics. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Clinical Pharmacogenetics Implementation Consortium (CPIC) has advanced clinical pharmacogenomics since 2009 by developing freely available, evidence‐based gene/drug guidelines. Covering 34 genes and 164 drugs, CPIC guidelines have become the global standard for translating pharmacogenomic test results into actionable prescribing decisions. This paper summarizes data highlighting CPIC’s pivotal role in accelerating the global adoption of pharmacogenomics and establishing itself as the leading resource for clinical implementation. To assess CPIC’s growth and impact, we analyzed member demographics, guideline characteristics, author composition, bibliometric data, database/API usage, and real‐world implementation using internal tracking, external databases (Scopus, iCite), website analytics, PubMed review (2019–2024), and CPIC member surveys (2012, 2024). CPIC has 28 active guidelines with international authorship and widespread adoption, garnering over 10,000 citations and 1.4 million views. Robust implementation is evident, with 85% of PubMed‐indexed pharmacogenomic implementation studies referencing CPIC guidelines. Additionally, 128 healthcare institutions and 40 commercial laboratories report using CPIC content. The CPIC API supports over 80,000 monthly queries, increasingly integrated into EHRs, including Epic’s foundational genomics module. Member surveys show a shift from scientific evidence concerns to practical barriers like clinician education, reimbursement, and EHR integration. CPIC has evolved from a guideline development initiative into a global leader in pharmacogenomics implementation, fostering collaboration, standardization, and sustainable integration into diverse healthcare settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacogeneticsHumansPractice Guidelines as Topic

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.
  • Department of Biomedical Data Science, Medicine, and Genetics, Stanford University, Stanford, California, USA.

ORCID-Profile: Kelly E Caudle, Michelle Whirl-Carrillo, Mary V Relling, James M Hoffman, Roseann S Donnelly, Cyrine E Haidar, Melissa S Bourque, Samantha Frear, Li Gong, Katrin Sangkuhl, Ryan Whaley, Teri E Klein

Förderung

  • NHGRI NIH HHS
  • National Institutes of Health (NIH)

Zitieren

APA

Caudle, K. E., Whirl-Carrillo, M., Relling, M. V., Hoffman, J. M., Donnelly, R. S., Haidar, C. E., Bourque, M. S., Frear, S., Gong, L., Sangkuhl, K., Whaley, R., & Klein, T. E. (2025). Advancing Clinical Pharmacogenomics Worldwide Through the Clinical Pharmacogenetics Implementation Consortium ( CPIC ). Clinical Pharmacology & Therapeutics, 118(6), 1512-1522. https://doi.org/10.1002/cpt.70005

Vancouver

Caudle KE, Whirl-Carrillo M, Relling MV, Hoffman JM, Donnelly RS, Haidar CE, et al. Advancing Clinical Pharmacogenomics Worldwide Through the Clinical Pharmacogenetics Implementation Consortium ( CPIC ). Clinical Pharmacology & Therapeutics. 2025;118(6):1512-1522. doi:10.1002/cpt.70005

BibTeX
@article{Caudle2025,
  author = {Caudle, Kelly E and Whirl-Carrillo, Michelle and Relling, Mary V and Hoffman, James M and Donnelly, Roseann S and Haidar, Cyrine E and Bourque, Melissa S and Frear, Samantha and Gong, Li and Sangkuhl, Katrin and Whaley, Ryan and Klein, Teri E},
  title = {Advancing Clinical Pharmacogenomics Worldwide Through the Clinical Pharmacogenetics Implementation Consortium ( CPIC )},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  volume = {118},
  number = {6},
  pages = {1512--1522},
  doi = {10.1002/cpt.70005}
}
Kostenlos starten →